在线客服: 点击这里给我发消息  新用户使用步骤:会员注册→充值→重新登入→进入资源
标题:Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches.
时间:2020-02-15 07:37:39
DOI:10.1586/egh.09.74
PMID:20136590
作者:von Hahn, Thomas; Steinmann, Eike; Ciesek, Sandra
关键词:antiviral therapy; chronic liver disease; experimental model systems; hepatitis C virus; interferon; polymerase inhibitor; protease inhibitor; ribavirin; viral lifecycle
出版源: 《Expert Rev Gastroenterol Hepatol》 ,4 (1) :63-79
摘要:Identified in 1989 as the cause of what was then known as hepatitis non-A non-B, the hepatitis C virus (HCV) continues to be a significant global public health threat, given that an estimated 123 million individuals are chronically infected and, thus, at risk for cirrhosis and hepatocellular carcinoma. After 20 years of basic and clinical research into HCV infection, the backbone of therapy has remained interferon, a drug that - in a different formulation - was already being employed before HCV was even identified. Nonetheless, research has overcome many obstacles that stood in the way of studying this pre-eminent human pathogen. Hard-won insights into its molecular biology have identified promising therapeutic targets, and we are now on the verge of an era where rationally designed therapeutics, also referred to as specifically targeted antiviral therapy for HCV, will reshape the treatment of hepatitis C. This article describes recent insights on the molecular biology of HCV and the efforts to translate them into clinical applications.
大小:5830 kb
页数:18 PAGES
下载: 点击下载
预览:

浏览器不支持嵌入PDF阅读,打开新页面在线阅读

本页内容由网络收集而来,版权归原创者所有,如有侵权请及时联系